Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SMG1 pseudogene 2 (SMG1P2) is a human pseudogene, meaning it is a DNA sequence similar to the functional SMG1 gene but is generally not transcribed or translated into a functional protein. It is not considered a therapeutic target nor does it have a known biological function or disease involvement. Most gene databases list it for cataloguing purposes only and it is not the subject of pharmacological or biomarker studies[4]. For context, the related functional gene SMG1 encodes a serine/threonine-protein kinase involved in nonsense-mediated mRNA decay (NMD) and cellular stress responses[2][5], but SMG1P2 does not encode such a protein. This entry is likely included in gene lists for reference or annotation of pseudogenes, but is not a receptor, enzyme, or any form of therapeutic target. There is no evidence in major scientific databases or literature indicating any direct biological or clinical relevance for SMG1P2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SMG1 pseudogene 2 (SMG1P2).